Clinical trial
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion…
NCT00001566 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001566 |
|---|---|
| Title | A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas |
| Official title | A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ewing's Sarcoma, Rhabdomyosarcoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | therapeutic autologous dendritic cells, indinavir sulfate, peripheral blood stem cell transplantation |
| Enrollment | 42 |
| Start date | Dec 1, 1996 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 4, 1999 |
| Last update posted | Jun 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: